The GLP is committed to full transparency. Download and review our 2019 Annual Report

Controversial ‘3-parent baby’ technique not effective for women over 36, fertility doctors warn

| | October 21, 2019

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

An experimental and much-hyped reproductive procedure that mixes DNA from three people is not effective at boosting the chances of having a baby for women ages 37 and older, according to doctors at a fertility clinic in Ukraine.

The technique, known as mitochondrial replacement therapy, involves taking a woman’s egg and shifting the majority of its DNA, known as the nucleus, into a hollowed-out donor egg.

The doctors at the Nadiya Clinic performed mitochondrial replacement therapy on 30 women ages 37 to 47 who were seeking treatment for infertility due to advanced age. Out of 109 lab-fertilized eggs, only 33 became embryos, and just three of those embryos were healthy enough to be implanted into patients. A fetal heartbeat was confirmed in only one patient, a 42-year-old woman who gave birth to a boy in March 2018. The authors report that the child is healthy.

Related article:  ‘Gene doping’ could be the future of athletics. But is that a bad thing?

In light of their results, the researchers recommend that women of so-called advanced maternal age, considered age 35 and older by fertility doctors, should not undergo mitochondrial replacement to increase their chances of having a baby.

Read full, original post: Controversial ‘3-Parent Baby’ Fertility Technique Fails to Deliver for Older Women

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend